Targeting the cancer lesion, not the whole prostate

被引:9
作者
Bedi, Nishant [1 ,2 ]
Reddy, Deepika [1 ,2 ]
Ahmed, Hashim U. [1 ,2 ]
机构
[1] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Imperial Urol, London, England
[2] Imperial Coll London, Dept Surg & Canc, Div Surg, Imperial Prostate, London, England
基金
英国惠康基金;
关键词
Prostate cancer; focal therapy; high-intensity focused ultrasound (HIFU); cryotherapy; index lesion; irreversible electroporation (IRE); vascular-targeted photodynamic therapy (VTP); focal brachytherapy; laser interstitial therapy (LITT); focal radiofrequency ablation (focal RFA); photodynamic therapy (PDT); INTENSITY FOCUSED ULTRASOUND; PROSPECTIVE MULTICENTRIC HEMIABLATION; FOCAL THERAPY; IRREVERSIBLE ELECTROPORATION; RADICAL PROSTATECTOMY; FUNCTIONAL OUTCOMES; INDEX LESION; FOLLOW-UP; BRACHYTHERAPY; CRYOTHERAPY;
D O I
10.21037/tau.2019.09.12
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Modern cancer treatment aims to conserve as much healthy tissue as possible. This has been challenging in the treatment of prostate cancer due to the difficulty in imaging the gland and concerns over leaving multifocal cancer untreated. With improvements in imaging and understanding of multifocal prostate cancer evidence now shows accurate treatment of just the primary focus of cancer or the index lesion can control progression or recurrence of the disease. Many different energy sources are now available to target the cancer lesion within the prostate with less significant side-effects on urinary and sexual function compared to radical treatment. Evidence shows that men value these functions highly and would even trade years of life in exchange for preserved retention of continence or erectile function. Focal treatment of prostate cancer aims to provide both cancer control and preservation of sexual and urinary functions so that men do not have to make a choice between the two. This is a treatment option that men clearly want and deserve.
引用
收藏
页码:1518 / 1525
页数:8
相关论文
共 56 条
  • [1] The PROMIS of MRI
    Ahmed, Hashim U.
    [J]. BJU INTERNATIONAL, 2016, 118 (01) : 7 - 7
  • [2] Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?
    Ahmed, Hashim Uddin
    Arya, Manit
    Freeman, Alex
    Emberton, Mark
    [J]. LANCET ONCOLOGY, 2012, 13 (11) : E509 - E517
  • [3] The Index Lesion and the Origin of Prostate Cancer
    Ahmed, Hashim Uddin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (17) : 1704 - 1706
  • [4] Ahmed HU WV, 2018, EVALUATING TRADE OFF
  • [5] Padeliporfi n vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
    Azzouzi, Abdel-Rahmene
    Vincendeau, Sebastien
    Barret, Eric
    Cicco, Antony
    Kleinclauss, Francois
    van der Poel, Henk G.
    Stief, Christian G.
    Rassweiler, Jens
    Salomon, Georg
    Solsona, Eduardo
    Alcaraz, Antonio
    Tammela, Teuvo T.
    Rosario, Derek J.
    Gomez-Veiga, Francisco
    Ahlgren, Goran
    Benzaghou, Fawzi
    Gaillac, Bertrand
    Amzal, Billy
    Debruyne, Frans M. J.
    Fromont, Gaelle
    Gratzke, Christian
    Emberton, Mark
    [J]. LANCET ONCOLOGY, 2017, 18 (02) : 181 - 191
  • [6] TOOKAD® Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer
    Azzouzi, Abdel-Rahmene
    Barret, Eric
    Moore, Caroline M.
    Villers, Arnaud
    Allen, Clare
    Scherz, Avigdor
    Muir, Gordon
    de Wildt, Michel
    Barber, Neil J.
    Lebdai, Souhil
    Emberton, Mark
    [J]. BJU INTERNATIONAL, 2013, 112 (06) : 766 - 774
  • [7] Focal Cryotherapy for Clinically Unilateral, Low-Intermediate Risk Prostate Cancer in 73 Men with a Median Follow-Up of 3.7 Years
    Bahn, Duke
    Abreu, Andre Luis de Castro
    Gill, Inderbir S.
    Hung, Andrew J.
    Silverman, Paul
    Gross, Mitchell E.
    Lieskovsky, Gary
    Ukimura, Osamu
    [J]. EUROPEAN UROLOGY, 2012, 62 (01) : 55 - 63
  • [8] Focal therapy in prostate cancer: A review of seven common controversies
    Bass, Edward J.
    Ahmed, Hashim U.
    [J]. CANCER TREATMENT REVIEWS, 2016, 51 : 27 - 34
  • [9] Radical Prostatectomy or Watchful Waiting in Prostate Cancer-29-Year Follow-up
    Bill-Axelson, Anna
    Holmberg, Lars
    Garmo, Hans
    Taari, Kimmo
    Busch, Christer
    Nordling, Stig
    Haggman, Michael
    Andersson, Swen-Olof
    Andren, Ove
    Steineck, Gunnar
    Adami, Hans-Olov
    Johansson, Jan-Erik
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) : 2319 - 2329
  • [10] The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer
    Bott, Simon R. J.
    Ahmed, Hashim U.
    Hindley, Richard G.
    Abdul-Rahman, Ahmad
    Freeman, Alex
    Emberton, Mark
    [J]. BJU INTERNATIONAL, 2010, 106 (11) : 1607 - 1611